Greater Cannabis Company (GCAN) Amortizatization of Intangibles (2017 - 2025)
Greater Cannabis Company (GCAN) recorded quarterly Amortizatization of Intangibles of $417.0 in Q1 2025, down 66.64% quarter-over-quarter from $1250.0 in Q4 2024, and down 66.64% on a YoY basis from $1250.0 in Q1 2024.
Greater Cannabis Company (GCAN) Amortizatization of Intangibles (2017 - 2025) Analysis & Trends
Greater Cannabis Company's Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $417.0 for Q1 2025.
- In Q1 2025, Amortizatization of Intangibles fell 66.64% year-over-year to $417.0; the TTM figure through Dec 2025 stood at $417.0 (down 91.66% YoY), while the FY2025 annual figure was $417.0, down 91.66% from the prior year.
- Amortizatization of Intangibles was $417.0 for Q1 2025 at Greater Cannabis Company, down from $1250.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $117746.0 in Q3 2021 to a low of $417.0 in Q1 2025.
- Historically, Amortizatization of Intangibles has averaged $26972.4 across 5 years, with a median of $1250.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles surged 714.22% in 2022, then slumped 98.73% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at $70339.0 in 2021, then surged by 39.81% to $98342.0 in 2022, then plunged by 98.73% to $1250.0 in 2023, then changed by 0.0% to $1250.0 in 2024, then tumbled by 66.64% to $417.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $417.0 (Q1 2025), $1250.0 (Q4 2024), and $1250.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Greater Cannabis Company | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 417.00 |
| Mar 31, 2025 | 417.00 |
| Dec 31, 2024 | 1,250.00 |
| Dec 31, 2024 | 1,250.00 |
| Sep 30, 2024 | 1,250.00 |
| Sep 30, 2024 | 1,250.00 |
| Jun 30, 2024 | 1,250.00 |
| Jun 30, 2024 | 1,250.00 |
| Mar 31, 2024 | 1,250.00 |
| Mar 31, 2024 | 1,250.00 |
| Dec 31, 2023 | 1,250.00 |
| Dec 31, 2023 | 1,250.00 |
| Sep 30, 2023 | 1,250.00 |
| Sep 30, 2023 | 1,250.00 |
| Jun 30, 2023 | 1,250.00 |
| Jun 30, 2023 | 1,250.00 |
| Mar 31, 2023 | 1,250.00 |
| Mar 31, 2023 | 1,250.00 |
| Mar 31, 2022 | 98,342.00 |
| Mar 31, 2022 | 98,342.00 |